Stoke Therapeutics IncNASDAQ:STOK
- LAST PRICE11.2700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.0000/ 1
- Ask / Lots12.8500/ 1
- Open / Previous Close--- / 11.2700
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STOK |
|---|---|---|
| 09:32 ET | 2327 | 11.21 |
| 09:33 ET | 200 | 11.33 |
| 09:35 ET | 1720 | 11.34 |
| 09:37 ET | 1500 | 11.42 |
| 09:39 ET | 1125 | 11.388 |
| 09:42 ET | 100 | 11.34 |
| 09:44 ET | 100 | 11.26 |
| 09:50 ET | 1271 | 11.21 |
| 09:51 ET | 492 | 11.16 |
| 09:53 ET | 2625 | 11.22 |
| 09:55 ET | 100 | 11.2 |
| 09:57 ET | 100 | 11.205 |
| 10:00 ET | 1070 | 11.205 |
| 10:02 ET | 100 | 11.24 |
| 10:04 ET | 1551 | 11.165 |
| 10:06 ET | 100 | 11.17 |
| 10:08 ET | 341 | 11.13 |
| 10:11 ET | 1135 | 11.2 |
| 10:15 ET | 400 | 11.3 |
| 10:18 ET | 100 | 11.31 |
| 10:20 ET | 300 | 11.35 |
| 10:22 ET | 300 | 11.33 |
| 10:24 ET | 100 | 11.3 |
| 10:27 ET | 2733 | 11.21 |
| 10:29 ET | 100 | 11.2 |
| 10:31 ET | 305 | 11.21 |
| 10:33 ET | 200 | 11.19 |
| 10:36 ET | 422 | 11.25 |
| 10:38 ET | 400 | 11.28 |
| 10:40 ET | 100 | 11.285 |
| 10:42 ET | 100 | 11.24 |
| 10:45 ET | 400 | 11.3132 |
| 10:47 ET | 900 | 11.32 |
| 10:49 ET | 200 | 11.38 |
| 10:51 ET | 100 | 11.365 |
| 10:54 ET | 1000 | 11.43 |
| 10:56 ET | 200 | 11.46 |
| 11:00 ET | 325 | 11.445 |
| 11:02 ET | 100 | 11.445 |
| 11:03 ET | 1447 | 11.405 |
| 11:05 ET | 2398 | 11.47 |
| 11:07 ET | 100 | 11.45 |
| 11:09 ET | 1100 | 11.44 |
| 11:12 ET | 100 | 11.41 |
| 11:14 ET | 100 | 11.4 |
| 11:16 ET | 961 | 11.45 |
| 11:18 ET | 1055 | 11.45 |
| 11:20 ET | 129 | 11.45 |
| 11:21 ET | 600 | 11.43 |
| 11:23 ET | 100 | 11.43 |
| 11:25 ET | 300 | 11.42 |
| 11:27 ET | 100 | 11.43 |
| 11:30 ET | 100 | 11.42 |
| 11:34 ET | 500 | 11.425 |
| 11:36 ET | 552 | 11.49 |
| 11:38 ET | 800 | 11.465 |
| 11:41 ET | 391 | 11.42 |
| 11:43 ET | 733 | 11.445 |
| 11:48 ET | 597 | 11.445 |
| 11:52 ET | 100 | 11.43 |
| 11:54 ET | 2147 | 11.51 |
| 11:59 ET | 100 | 11.53 |
| 12:01 ET | 419 | 11.52 |
| 12:03 ET | 706 | 11.5437 |
| 12:06 ET | 800 | 11.56 |
| 12:12 ET | 2668 | 11.59 |
| 12:14 ET | 1825 | 11.575 |
| 12:17 ET | 200 | 11.57 |
| 12:19 ET | 924 | 11.57 |
| 12:21 ET | 200 | 11.575 |
| 12:26 ET | 100 | 11.59 |
| 12:28 ET | 601 | 11.6048 |
| 12:30 ET | 100 | 11.615 |
| 12:32 ET | 732 | 11.63 |
| 12:33 ET | 2100 | 11.64 |
| 12:35 ET | 100 | 11.645 |
| 12:37 ET | 100 | 11.67 |
| 12:44 ET | 250 | 11.675 |
| 12:46 ET | 325 | 11.694 |
| 12:48 ET | 100 | 11.69 |
| 12:50 ET | 221 | 11.69 |
| 12:51 ET | 508 | 11.68 |
| 12:53 ET | 100 | 11.69 |
| 12:55 ET | 200 | 11.705 |
| 12:57 ET | 500 | 11.725 |
| 01:00 ET | 1080 | 11.68 |
| 01:02 ET | 1700 | 11.6 |
| 01:06 ET | 100 | 11.59 |
| 01:08 ET | 100 | 11.58 |
| 01:09 ET | 100 | 11.59 |
| 01:15 ET | 250 | 11.59 |
| 01:20 ET | 389 | 11.59 |
| 01:24 ET | 300 | 11.61 |
| 01:26 ET | 200 | 11.63 |
| 01:29 ET | 182 | 11.6015 |
| 01:31 ET | 600 | 11.62 |
| 01:33 ET | 592 | 11.61 |
| 01:36 ET | 100 | 11.6 |
| 01:38 ET | 200 | 11.615 |
| 01:40 ET | 300 | 11.58 |
| 01:42 ET | 500 | 11.54 |
| 01:44 ET | 100 | 11.57 |
| 01:45 ET | 100 | 11.57 |
| 01:47 ET | 400 | 11.54 |
| 01:49 ET | 100 | 11.545 |
| 01:51 ET | 639 | 11.51 |
| 01:54 ET | 100 | 11.5 |
| 01:58 ET | 100 | 11.505 |
| 02:00 ET | 688 | 11.4815 |
| 02:07 ET | 100 | 11.47 |
| 02:09 ET | 500 | 11.45 |
| 02:12 ET | 200 | 11.41 |
| 02:16 ET | 281 | 11.41 |
| 02:21 ET | 100 | 11.38 |
| 02:25 ET | 400 | 11.4 |
| 02:27 ET | 300 | 11.4 |
| 02:30 ET | 700 | 11.39 |
| 02:32 ET | 100 | 11.39 |
| 02:34 ET | 820 | 11.445 |
| 02:36 ET | 300 | 11.44 |
| 02:39 ET | 100 | 11.45 |
| 02:41 ET | 125 | 11.47 |
| 02:43 ET | 800 | 11.4215 |
| 02:50 ET | 2392 | 11.395 |
| 02:52 ET | 600 | 11.43 |
| 02:57 ET | 600 | 11.41 |
| 02:59 ET | 1000 | 11.375 |
| 03:01 ET | 3000 | 11.3714 |
| 03:03 ET | 300 | 11.345 |
| 03:06 ET | 100 | 11.355 |
| 03:08 ET | 100 | 11.355 |
| 03:10 ET | 2288 | 11.395 |
| 03:12 ET | 2997 | 11.39 |
| 03:14 ET | 1415 | 11.4 |
| 03:15 ET | 768 | 11.39 |
| 03:21 ET | 200 | 11.41 |
| 03:24 ET | 100 | 11.41 |
| 03:26 ET | 1728 | 11.395 |
| 03:28 ET | 3195 | 11.42 |
| 03:30 ET | 2580 | 11.4121 |
| 03:32 ET | 900 | 11.38 |
| 03:33 ET | 815 | 11.37 |
| 03:35 ET | 3335 | 11.37 |
| 03:37 ET | 400 | 11.35 |
| 03:39 ET | 200 | 11.33 |
| 03:42 ET | 2100 | 11.35 |
| 03:44 ET | 3965 | 11.37 |
| 03:46 ET | 1756 | 11.4 |
| 03:48 ET | 800 | 11.43 |
| 03:50 ET | 1600 | 11.39 |
| 03:51 ET | 200 | 11.38 |
| 03:53 ET | 400 | 11.37 |
| 03:55 ET | 300 | 11.38 |
| 03:57 ET | 2261 | 11.34 |
| 04:00 ET | 53835 | 11.27 |
Nov 6, 2024
DJ Stoke Therapeutics Price Target Maintained With a $35.00/Share by HC Wainwright & Co., from 6:25AM ET on Wednesday Nov 06, 2024 by Dow Jones
6:25AM ET on Wednesday Nov 06, 2024 by Dow JonesDJ Stoke Therapeutics Price Target Maintained With a $22.00/Share by Needham, from 4:56AM ET on Wednesday Nov 06, 2024 by Dow Jones
4:56AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
*DJ Stoke Therapeutics 3Q Loss/Shr 47c >STOK, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 05, 2024 by Dow JonesStoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Stoke Therapeutics Inc | 596.9M | -5.4x | --- |
Dianthus Therapeutics Inc | 599.9M | -8.1x | --- |
Mereo BioPharma Group PLC | 566.2M | 0.0x | --- |
Immunome Inc | 586.7M | -1.6x | --- |
Altimmune Inc | 597.4M | -5.4x | --- |
Kezar Life Sciences Inc | 556.0M | -0.6x | --- |
Company Information
Stoke Therapeutics, Inc. is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with ribonucleic acid (RNA)-based medicines. The Company, through its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach, is engaged in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. TANGO aims to restore missing proteins by increasing or stoking protein output from healthy genes, thus compensating for the non-functioning copy of the gene. The Company is pursuing the development of STK-002 for the treatment of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. The Company’s initial focus is haploinsufficiency and diseases of the central nervous system and the eye.
Contact Information
- Headquarters
- 45 WIGGINS AVENUEBEDFORD, MA, United States 01730
- Phone
- 781-430-8200
- Fax
- 302-531-3150
Executives
- Independent Chairman of the Board
- Seth Harrison
- Chief Executive Officer, Director
- Edward Kaye
- Chief Financial Officer
- Thomas Leggett
- General Counsel, Corporate Secretary
- Jonathan Allan
- Chief Commercial Officer
- Jason Hoitt
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $596.9M |
|---|---|
Revenue (TTM) | $16.7M |
Shares Outstanding | 53.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-2.10 |
Book Value | $3.47 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | 35.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -700.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
